The FDA Finally Visited an Indian Drug Factory Linked to U.S. Deaths. It Found Problems.
The inspection comes after a ProPublica investigation revealed that drugs made at the Glenmark Pharmaceuticals plant ...
Glenmark Pharmaceuticals Ltd: Glenmark Pharmaceuticals Launches Pioneering Nutrition Program to Fight Malnutrition in the Philippines
Glenmark Pharmaceuticals Ltd. (Glenmark), a leading research-led, global pharmaceuticals company has partnered with, Health Futures Foundation ...
Glenmark Pharma share rises 2% on securing USFDA nod; key details here
Glenmark Pharma's stock rose after it said Glenmark Pharmaceuticals Inc., USA, has received final approval from the USFDA for ...
Glenmark Pharma gains as arm gets USFDA nod for Olopatadine Ophthalmic solution
Glenmark Pharmaceuticals rose 1.95% to Rs 1,506.95 after its US subsidiary, Glenmark Pharmaceuticals Inc., USA, received approval from the US Food & Drug Administration (USFDA) for its Olopatadine ...
Drug Store News20h
Glenmark receives FDA OK for generic Pataday OTC
Glenmark has received the Food and Drug Administration’s clearance for olopatadine hydrochloride ophthalmic solution, 0.2% OTC, which is the generic of Alcon’s Pataday Once Daily Relief Ophthalmic ...
India Infoline28d
Glenmark Pharmaceuticals Ltd Summary
Glenmark Pharmaceuticals Ltd was incorporated in November 18th, 1977. The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological ...
Morningstar26d
Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 10 mg/10 mL (1 mg/mL) Multiple-Dose Vial
Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...
Longview News-Journal22d
Glenmark Pharmaceuticals Inc., USA acquires and launches Acetylcysteine Injection, 6 gm/30 mL (200 mg/mL) Single-Dose Vials
Glenmark Pharmaceuticals Ltd. (BSE: 532296) (NSE: GLENMARK) is a research–led, global pharmaceutical company, having a presence across Branded, Generics, and OTC segments; with a focus on ...
Day 1 after diabetes drug Empagliflozin goes off patent, generics go to town with it
Generic versions of diabetes drug Empagliflozin launched in India, crashing prices by 80-90% on day one post-patent expiry.
Business Today5d
Glenmark Pharmaceuticals Ltd (GLENMARK) Share Price
Auditor/Auditors for Glenmark Pharmaceuticals Ltd is/are Suresh Surana & Associates LLP. In the main management, Glenn Saldanha is chairman and is the company secretary for Glenmark ...